Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference December 3
Homerun Resources Inc. Executes NREL Enduring Thermal Energy Storage Global Intellectual Property Agreement Including New Patent Application and EMS Integration
